3,548
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany

Pages 5296-5303 | Received 03 Aug 2021, Accepted 01 Nov 2021, Published online: 14 Dec 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.